| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |